Effectiveness of IFN-gamma for Liver Abscesses in Chronic Granulomatous Disease
- 1 July 1999
- journal article
- case report
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 19 (7) , 705-710
- https://doi.org/10.1089/107999099313541
Abstract
In chronic granulomatous disease, interferon-gamma (IFN-gamma) significantly reduces the incidence and severity of recurrent infections, but its effectiveness administered ex novo during acute infection has been reported in only one case. In this report, we describe two adult brothers with chronic granulomatous disease treated successfully with IFN-gamma for acute liver abscesses. Two brothers with severe recurrent infections of unknown origin were hospitalized for septic fever, malnutrition, and ultrasonographic evidence of liver abscess. Autosomal recessive chronic granulomatous disease was diagnosed based on lack of superoxide anion production by phagocytes and absence of p47-phox protein. An antibiotic regimen specifically directed against Staphylococcus aureus was ineffective, whereas treatment with 50 mu g/m2 IFN-gamma s.c. thrice weekly induced complete healing with scarring within 3 months. No septic recurrence was observed during a 4-year follow-up period. In chronic granulomatous disease, IFN-gamma is effective not only in preventing but also in healing life-threatening acute infections.Keywords
This publication has 26 references indexed in Scilit:
- Interleukin‐10 Down‐Regulates Oxidative Metabolism and Antibody‐Dependent Cellular Cytotoxicity of Human NeutrophilsScandinavian Journal of Immunology, 1997
- Functional Reconstitution of Oxidase Activity in X-Linked Chronic Granulomatous Disease by Retrovirus-Mediated Gene TransferExperimental Cell Research, 1996
- Recombinant human interferon-gamma in patients with chronic granulomatous disease ? European follow up studyEuropean Journal of Pediatrics, 1995
- Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteinsClinical and Experimental Immunology, 1992
- Chronic Granulomatous DiseaseAnnual Review of Medicine, 1992
- Interferon Gamma-1bDrugs, 1992
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988
- Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.Journal of Clinical Investigation, 1987
- Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous LeprosyNew England Journal of Medicine, 1986
- Chronic Granulomatous DiseaseMedicine, 1983